RECORDS ARE PUBLISHED REGULATORY ACTIONS. FIELDS THE ISSUING AUTHORITY DID NOT PUBLISH ARE MARKED AS NOT STATED, NEVER FILLED IN.
Drug Eye AfricaNational Actions, Continental Reach
Ler esta página em: English · العربية · Français · Português
Register / Egypt / DEA-EG-2023-0008
Egyptian Drug Authority · Egypt
DEA-EG-2023-0008
Tier 1 · Regulator-publishedUnclassifiedAviso ao públicoStatus · active
Issuing authority
Egyptian Drug Authority (EDA)
Authority reference
Periodic report no. (8) For 2023
Date issued
Jun 2023
Recorded by us
2026-09-06 19:45:29 UTC
Produto
Twinzol Eye Drop
INN / active substance
Not stated by the issuing authority
Dosage form
Not stated by the issuing authority
Strength
Not stated by the issuing authority
Fabricante
Not stated by the issuing authority
Manufacturer country
Not stated by the issuing authority
MAH or importer
Not stated by the issuing authority
Números de lote
0622115
Prazos de validade
Not published with the notice
Action type
Aviso ao público
Classificação
Not stated by the issuing authority
Indicative severity
Not assessed by Drug Eye Africa
Defect category
Falsificado
Product type
Not stated by the issuing authority
ATC code
Not stated by the issuing authority
Affected markets
Egypt — no market beyond the issuing country was named on the notice
Cross-border event
Not linked to a cross-border event
Texto do aviso
@egyptiandrugauthority www.edaegypt.gov.eg 15301 تحذر هيئة الدواء المصرية من العبوات المقلدة من المستحضر التالي حيث يمكن التفرقة ظاهرياً بين العبوات الأصلية والعبوات المقلدة للمستحضر المذكور -وذلك بناءً على ماورد إلينا من الشركة صاحبة المستحضر- كالآتى: منشور غش تجاري Twinzol Eye Drop 0622115تشغيلة رقم Orchediaالشركة المصنعة وجميع التشغيلات الأخرى التي تتفق مع المواصفات المذكورة بالعبوة المقلدة كما هو وارد بالمنشور يونيو ٣٢٠٢ Exforge HCT 5mg/160mg/12.5mg B59ZX4 , BDPV3 , BDPW8تشغيلة رقم Novartis Pharma S.A.Eالشركة المصنعة :شركة egyptiandrugauthority www.edaegypt.gov.eg 15301 في حال وجود شكوى يرجى الرجوع للصيدلي للتأكد من العبوة او الاتصال على الخط الساخن ١٠٣٥١ او www.edaegypt.gov.egالابلاغ عبر الموقع الإلكتروني للهيئة Twinzol Eye Drop 0622115تشغيلة رقم Orchediaالشركة المصنعة Exforge HCT 5mg/160mg/12.5mg B59ZX4 , BDPV3 , BDPW8تشغيلة رقم Novartis Pharma S.A.Eالشركة المصنعة :شركة egyptiandrugauthority www.edaegypt.gov.eg 15301 في حال وجود شكوى يرجى الرجوع للصيدلي للتأكد من العبوة او الاتصال على الخط الساخن ١٠٣٥١ او www.edaegypt.gov.egالابلاغ عبر الموقع الإلكتروني للهيئة Twinzol Eye Drop 0622115تشغيلة رقم Orchediaالشركة المصنعة Exforge HCT 5mg/160mg/12.5mg B59ZX4 , BDPV3 , BDPW8تشغيلة رقم Novartis Pharma S.A.Eالشركة المصنعة :شركة egyptiandrugauthority www.edaegypt.gov.eg 15301 في حال وجود شكوى يرجى الرجوع للصيدلي للتأكد من العبوة او الاتصال على الخط الساخن ١٠٣٥١ او www.edaegypt.gov.egالابلاغ عبر الموقع الإلكتروني للهيئة Twinzol Eye Drop 0622115تشغيلة رقم Orchediaالشركة المصنعة
Original language: ar
Texto do aviso em inglês
Trade-counterfeiting circular. The Egyptian Drug Authority warns against counterfeit packs of the following product: Twinzol Eye Drop, batch number 0622115, manufactured by Orchidia, together with every other batch matching the specifications given on the counterfeit pack. Genuine and counterfeit packs can be told apart by sight, on the basis of what the company that owns the product has reported to the Authority.
Machine translation, produced by Drug Eye Africa and not checked by the issuing authority. The authority stated only the text above it.
Estado
Em vigor
Superseded by
Not superseded. This is the current version.
Version
1

Provenance

Verification tier 1

Where this record came from, and what is held to show it.

Primary source
https://www.edaegypt.gov.eg/media/ts4ajc3y/%D9%85%D9%86%D8%B4%D9%88%D8%B1-%D8%AF%D9%88%D8%B1%D9%8A-%D8%B1%D9%82%D9%85-8-%D9%84%D8%B3%D9%86%D8%A9-2023.pdf
Copy of the source
Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.
Ask us for it and check it against the fingerprint below.
Fingerprint
eb608762e03e3d2643cf00a390b94c5840072773ddf0838d90c8d8ec38f868a1
SHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
Copy taken
2026-09-06 20:36:46 UTC

Related actions elsewhere

Same stated defect
ReferenceDateCountryProductBatchesActionClassSource
DEA-XXX-2026-000303 Jul 2026XXDARZALEX (daratumumab)MYS7381 · STV1K01Public warningUnclassifiedTier 1 · Regulator-published
DEA-EG-2026-0070Jul 2026EGTagrisso 80 mg film-coated tabletsFESTPublic warningUnclassifiedTier 1 · Regulator-published
DEA-XXX-2026-000216 Jun 2026XXJAKAVI (ruxolitinib)none publishedPublic warningUnclassifiedTier 1 · Regulator-published
DEA-EG-2026-0062Jun 2026EGCOLOVERIN-D 30 film Coated Tablets251035APublic warningUnclassifiedTier 1 · Regulator-published
DEA-EG-2026-0061Jun 2026EGFLOPADEX 8mg Hard gelatin capsules 302504626Public warningUnclassifiedTier 1 · Regulator-published
DEA-EG-2026-0060Jun 2026EGTears Guard Artificial Tears & Lubricant (Sterile Ophthalmic Solution)0425118Public warningUnclassifiedTier 1 · Regulator-published
Cite this record
Drug Eye Africa (2023). DEA-EG-2023-0008: Twinzol Eye Drop — Aviso ao público, Egyptian Drug Authority. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/eg/2023/dea-eg-2023-0008

Version history

v1Manufacturer removed: the notice describes the packaging as counterfeit (correction)
—Corrections appear here and in the site-wide log. Records are superseded, never deleted.

Verification

Tier 1 — Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.

Indexing

This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.

This record as data

/api/v1/notices/DEA-EG-2023-0008